Other groups have illustrated that the expression of cancer stemness genes (OCT4, NANOG) induced by elevation of IGF-1/IGF-1R, correlates with high tumor recurrence in HCC patients [134] and sorafenib resistance. This evidence concerns the gene IGF1R and hepatocellular carcinoma.